Clinical trials / NCT04318145
NCT04318145Phase 2Terminated

Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects

Study sponsor: Palatin Technologies, Inc · PTN

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2023-12-08Actual
Enrollment · participants15Actual
Source updated2025-12-15Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 5 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

55 participants (planned)

+ After

15 participants (actual)

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

31 Mar 2022

+ After

8 Dec 2023

Recruitment status changed

− Before

Recruiting

+ After

Terminated

Check registry source